Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. I. Mitogen-activated protein kinase cascade

Neuroscience

Volumn 105, Issue 4, 2001, Pages 1031-1040

  Holzer, M ^a   Gartner U ^a   Klinz, F J ^b   Narz, F ^b   Heumann, R ^b   Arendt, Th ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Mitogen activated protein kinase; Protein phosphorylation; Signal transduction; Synapsin I promoter; Tau protein; Transgenic animals

Indexed keywords

CYTOSKELETON PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN P21; PROTEIN P70S6; PROTEIN P90RSK; RAF PROTEIN; SYNAPSIN I; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CYTOSKELETAL PROTEINS; ENZYME ACTIVATION; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 0035934247     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00245-7     Document Type: Article

References (78)

1. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
2. Activation of mitogen-activated protein kinase in BC3H1 myocytes by fluoroaluminate
3. Perisomatic sprouts immunoreactive for nerve growth factor receptor and neurofibrillary degeneration affect different neuronal populations in the basal nucleus in patients with Alzheimer's disease
4. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease
5. Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A
6. Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A
7. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease
8. Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease - A quantitative Golgi investigation
9. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: Implication of phosphoprotein phosphatase involvement
10. Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease
11. Intact Ras function is required for sustained activation and nuclear translocation of extracellular signal-regulated kinases in nerve growth factor-stimulated PC12 cells
12. Ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons
13. Ras p21 protein promotes survival and differentiation of human embryonic neural crest-derived cells
14. Brain interleukin-1β in Alzheimer's disease and vascular dementia
15. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus
16. Trk receptor alterations in Alzheimer's disease
17. Nerve growth factor and ras regulate β-amyloid precursor protein gene expression in PC12 cells
18. Detection of NGF-like activity in human brain tissue: Increased levels in Alzheimer's disease
19. Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade
20. Mitogen activated protein (MAP) kinase transforms tau-protein into an Alzheimer-like state
21. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type
22. The role of interleukin-6 in certain age-related diseases
23. Neuronal apoptosis is associated with a decrease in tau mRNA expression
24. Hepatocyte growth factor (HGF/SF) in Alzheimer's disease
25. Neuronal alterations in patients with dementia: A Golgi study on biopsy samples
26. A sensitive, high volume, colorimetric assay for protein phosphatases
27. Regulated cleavage of the Alzheimer amyloid precursor protein: Molecular and cellular basis
28. ras in Alzheimer pathology
29. 1: Implications for Alzheimer's disease
30. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
31. Induction of basic fibroblast growth factor in Alzheimer's disease pathology
32. Secreted beta amyloid precursor protein stimulates mitogen activated protein kinase and enhances tau phosphorylation
33. Post-translational processing of p21ras is two step and involves carboxyl-methylation and carboxy-terminal proteolysis
34. All ras proteins are poly-isoprenylated but only some are palmitoylated
35. Neurotrophin signaling
36. Transgenic activation of ras in neurons promote hypertrophy and protects from lesion-induced degeneration
37. Alterations in neurotrophins and neurotrophin receptors in Alzheimer's disease
38. The 5′-flanking region of the rat synapsin I gene directs neuron-specific and developmentally regulated reporter gene expression in transgenic mice
39. Activation of MAPK-cascade and phosphorylation of cytoskeletal proteins after neuron-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology
40. Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage
41. Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments
42. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia
43. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
44. The binding of basic fibroblast growth factor to Alzheimer's neurofibrillary tangles and senile plaques
45. Degradation of tau by lysosomal enzyme cathepsin D: Implication for Alzheimer neurofibrillary degeneration
46. Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation
47. Phosphorylation of tau in situ: Inhibition of calcium-dependent proteolysis
48. Phosphorylation of tau by glycogen synthase kinase-3β in intact mammalian cells: The effects on the organization and stability of microtubules
49. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia
50. Dynamic fatty acylation of p21N-ras
51. PDGF is associated with neuronal and glial alterations of Alzheimer's disease
52. Microtubular reorganization and dendritic growth response in Alzheimer's disease
53. Signal transduction abnormalities in Alzheimer's disease: Evidence of a pathogenic stimulus
54. Characterization of tau phosphorylation in glycogen synthase kinase-3 and cyclin dependent kinase-5 activator (p23) transfected cells
55. Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway
56. Activation of a PP2A-like phosphatase and dephosphorylation of τ protein characterize onset of the execution phase of apoptosis
57. Localization and subcellular distribution of cellular ras gene products in the rat brain
58. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease
59. Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques
60. The phosphorylation and activation of B-raf in PC12 cells stimulated by nerve growth factor
61. A simplification of the protein assay method of Lowry et al., which is more generally applicable
62. Increase of c-fos and ras oncoproteins in the denervated neuropil of the rat dentate gyrus
63. Knockout mouse foult lines
64. Ras-signaling pathways: Positive and negative regulation of tau expression in PC12 cells
65. The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells
66. Function of Ras as a molecular switch in signal transduction
67. Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1
68. Activation of Raf as a result of recruitment to the plasma membrane
69. Basic fibroblast growth factor in Alzheimer's disease
70. Epidermal growth factor receptor expression in demented and aged human brain
71. Oncogenesis and altered differentiation induced by activated Ras in neuroblasts of transgenic mice
72. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type
73. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases
74. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase
75. Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease
76. Calcineurin inhibition prevents calpain-mediated proteolysis of tau in differentiated PC12 cells
77. Brefeldin A-induced apoptosis is expressed in rat neurons with dephosphorylated tau protein